8 results match your criteria: "Brigham and Women's Hospital Department of Emergency Medicine[Affiliation]"

The Lāhainā Wildfires and 'Āina Connectedness in the Face of Climate Disasters.

JAMA Intern Med

December 2024

County of Maui, Office of Recovery, Health and Social Services Recovery Support Function, Wailuku, Hawai'i.

View Article and Find Full Text PDF

Semaglutide, COVID-19 Mortality, and the Power of Harnessing Ongoing Clinical Trials During Unexpected Outbreaks.

J Am Coll Cardiol

October 2024

Brigham and Women's Hospital Department of Emergency Medicine, Mass General Brigham Division of Health Services Research, Harvard Medical School, Boston, Massachusetts, USA. Electronic address:

View Article and Find Full Text PDF
Article Synopsis
  • The study examines the use of opioid analgesics by patients with urolithiasis after being treated in the emergency department, highlighting the prevalence of opioid prescriptions among these patients.
  • Data analysis revealed that 79% of the 892 patients studied received opioid prescriptions at discharge, and those prescribed opioids were significantly more likely to continue using them in the days following their ED visit.
  • The findings suggest that patients who are given opioids at discharge are more likely to keep using them, regardless of their pain status at discharge, indicating potential implications for ongoing opioid use post-treatment.
View Article and Find Full Text PDF

Objective: Previous research has suggested caution about opioid analgesic usage in the emergency department (ED) setting and raised concerns about variations in prescription opioid analgesic usage, both across institutions and for whom they are prescribed. We examined opioid analgesic usage in ED patients with suspected urolithiasis across fifteen participating hospitals.

Methods: This is a secondary analysis of a clinical trial including adult ED patients with suspected urolithiasis.

View Article and Find Full Text PDF

Background: Multimorbidity is a major driver of physical and cognitive impairment, but rates of decline are also related to ageing. We sought to determine trajectories of decline in a large cohort by disease status, and examined their correspondence with biomarkers of ageing processes including growth hormone, sex steroid, inflammation, visceral adiposity and kidney function pathways.

Methods: We have followed the 5888 participants in the Cardiovascular Health Study (CHS) for healthy ageing and longevity since 1989-90.

View Article and Find Full Text PDF